glp-1 vs sglt2 weight loss Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity | Drugs Liver gains beyond glycemic control:

Heterogeneity tests using Cochrans Q revealed moderate heterogeneity for anxiety disorders ( P = 0.009), suggesting some variability in effects across datasets

While launch brands may offer payer rebates to improve coverage, they also frequently deploy patient support programs that improve patient access while payer coverage ramps up

Food noise significantly reduced for most

While all GLP-1 medications may promote some weight loss, three drugs are specifically indicated for chronic weight management: Zepbound (tirzepatide) Wegovy (semaglutide) Saxenda (liraglutide) Multiple clinical trials have found that each of these medications can help people lose 5%-20% or more of their body weight though research suggests that some may be more effective than others